EnteroMedics Inc news

   Watch this stock
Showing stories 1 - 10 of about 87   

Articles published

ETRM 5.84 0.00 (0.00%)
price chart
Here's What Happened With EnteroMedics Inc (NASDAQ:ETRM) On Tuesday
EnteroMedics Inc (NASDAQ:ETRM) ran up early morning on Tuesday, as markets loaded up ahead of a prescheduled conference call that was set to take place at 11am EST.
EnteroMedics Reports Fourth Quarter 2016 Financial Results  PR Newswire (press release)
ENTEROMEDICS INC. (NASDAQ:ETRM) Files An 8-K Results of Operations and ...  Market Exclusive
EnteroMedics Inc (NASDAQ:ETRM) Is This Week's Biotech Runner
At the beginning of the week we highlighted EnteroMedics Inc (NASDAQ:ETRM) as one to watch. We noted that the company could run up on positive news flow, as it moved towards securing some insurance coverage for its lead product, vBloc.
Will a 20000 Dow Happen This Year? EnteroMedics Inc (NASDAQ:ETRM), Gevo Inc ...  Traders350
EnteroMedics Inc. (Nasdaq: ETRM) Makes Larges Gains in Pre-Market  StockNewsUnion
EnteroMedics' vBloc� Neurometabolic Therapy Featured on "The Doctors" TV Show
ST. PAUL, Minn., March 13, 2017 /PRNewswire/ -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that its ...
Stock Update (NASDAQ:ETRM): EnteroMedics Inc's vBloc� Neurometabolic ...  Smarter Analyst
EnteroMedics Announces Pricing of $16.5 Million Underwritten Public Offering
18, 2017 /PRNewswire-USNewswire/ -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced the pricing of an ...
EnteroMedics: Lose Weight Or Lose Your Money?  Seeking Alpha
Stock in Focus: EnteroMedics Inc. (NASDAQ:ETRM)  TopChronicle
EnteroMedics Announces 1-for-70 Reverse Stock Split
23, 2016 /PRNewswire/ -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the EnteroMedics Board of ...
Commercial Patient Data Confirms Success of EnteroMedics' vBloc� Therapy in ...
ST. PAUL, Minn., Dec. 15, 2016 /PRNewswire/ -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced an ...
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating EnteroMedics ...
NEW YORK, Feb. 21, 2017 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of ...
BRIEF-Enteromedics Inc files for a mixed shelf of upto $75 mln - SEC filing
BEIJING, March 21 China's economic growth is likely to slow to 6.5 percent this year and cool further to 6.3 percent in 2018, the OECD said, though exports are set to pick up as global demand strengthens.
EnteroMedics Announces Appointment of Scott Youngstrom as Chief Financial ...
7, 2016 /PRNewswire/ -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced the appointment of Scott Youngstrom ...
EnteroMedics to Host vBloc� Therapy Commercialization and Corporate Update ...
ST. PAUL, Minn., Nov. 30, 2016 /PRNewswire/ -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that it will ...